Contrast developer Advanced Magnetics has begun phase II trials of its lead development product, Code 7228, for MR angiography. The trial’s principal investigator will be Dr. Martin Prince of Weill Cornell Medical College and the New York Weill Cornell Medical Center of New York-Presbyterian Hospital, according to the firm.